Coronary heart disease and HRT in France: MISSION study prospective phase results.

about

Coronary heart disease and HRT in France: MISSION study prospective phase results.

Item

http://www.wikidata.org/entity/Q44251617

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Coronary heart disease and HRT in France: MISSION study prospective phase results.

@en

Coronary heart disease and HRT in France: MISSION study prospective phase results.

@nl

type

Item

label

Coronary heart disease and HRT in France: MISSION study prospective phase results.

@en

Coronary heart disease and HRT in France: MISSION study prospective phase results.

@nl

prefLabel

Coronary heart disease and HRT in France: MISSION study prospective phase results.

@en

Coronary heart disease and HRT in France: MISSION study prospective phase results.

@nl

P1476

Coronary heart disease and HRT in France: MISSION study prospective phase results.

@en

P2093

Drazen Postruznik

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Daures

http://www.w3.org/2001/XMLSchema#string

Marie-Christine Micheletti

http://www.w3.org/2001/XMLSchema#string

Pia De Reilhac

http://www.w3.org/2001/XMLSchema#string

Pierre Mares

http://www.w3.org/2001/XMLSchema#string

Thierry Chevallier

http://www.w3.org/2001/XMLSchema#string

P2860

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.

Estrogen plus progestin and the risk of coronary heart disease.

Hormone therapy to prevent disease and prolong life in postmenopausal women.

IMS updated recommendations on postmenopausal hormone therapy.

Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study.

Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis.

Ageing, oestrogen, platelets and thrombotic risk.

P304

696-700

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09513590802454935

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19172539

http://www.w3.org/2001/XMLSchema#string